CXC chemokine receptor 4 expression and function in human astroglioma cells

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Astrocytes are key glial cells in the central nervous system (CNS).
• Astrocytes produce chemokines, crucial for leukocyte function in the diseased brain.
• Human astrocytes and astroglioma cells produce various CXC and CC chemokines in response to inflammatory cytokines.

Purpose of the Study:

• To investigate chemokine receptor expression and function in human astroglioma cells.
• To determine the role of CXC chemokine receptor 4 (CXCR4) in astroglioma cells.
• To elucidate the signaling pathways involved in CXCR4-mediated chemokine production.

Main Methods:

• Treatment of astroglioma cells with cytokines (TNF-alpha, IL-1beta) to assess CXCR4 mRNA and protein expression.
• Generation of stable astroglioma transfectants with high CXCR4 levels.
• Stimulation of CXCR4-expressing cells with stromal cell-derived factor-1alpha (SDF-1alpha).
• Analysis of intracellular calcium levels, mitogen-activated protein kinase (MAPK) activation (ERK2), and chemokine expression.
• Use of U0126, an ERK1/2 inhibitor, to investigate signaling pathways.

Main Results:

• Cytokine treatment (TNF-alpha, IL-1beta) enhanced CXCR4 mRNA and protein expression in astroglioma cells.
• SDF-1alpha stimulation of CXCR4-expressing cells activated ERK2 MAPK and increased intracellular calcium.
• SDF-1alpha induced the expression of monocyte chemoattractant protein-1, IL-8, and IFN-gamma-inducible protein-10.
• The ERK signaling pathway was essential for SDF-1alpha-induced chemokine expression.

Conclusions:

• Astroglioma cells express functional CXCR4, a receptor for SDF-1alpha.
• CXCR4 signaling in astroglioma cells activates the ERK pathway.
• This pathway leads to the production of chemokines involved in inflammation and angiogenesis.
• CXCR4-mediated signaling represents a potential mechanism for chemokine release in astroglioma.